Call Made For More Funding For UK Life Sciences
Date posted:
News
A new government-commissioned report from geneticist and immunologist John Bell has made the call for further funding of basic science, further incentives for manufacturing and more effective cooperation between the NHS and drugmakers – part of the UK’s plans to help support the economy for Brexit and what comes after.
According to Reuters, Mr Bell is also suggesting that four UK life sciences companies be created that are valued at over £20 billion in the next decade, which would help bring in 2,000 new discovery scientists from around the world and also help deliver a 50 per cent hike in the number of clinical trials.
He wants to set up Health Advanced Research Programme as well, so that long-term projects can be prioritised that focus on innovative technologies like understanding the biology of ageing, or the use of artificial intelligence in healthcare.
Commenting on the strategy, Pascal Soriot – chief executive of AstraZeneca – was quoted by the news source as saying that it should “provide a more predictable environment for future investment decisions and ensure the UK remains open for innovation as it prepares to exit the EU”.
This comes after the House of Lords Science and Technology Committee launched an enquiry into how the life sciences strategy in the UK could be enhanced so as to bring it up to scratch in relation to other countries around the world.
The aim is to make the life sciences sector more appealing for investments so that challenges like cancer and dementia can be met more effectively.
For help with life science sales, get in touch with the Voicentric team today.